ASH 2013 - Andrew Artz on Allogeneic Transplant for High Risk Myelodysplastic Syndromes and AML

2 Views
administrator
administrator
07/04/23

From ASH 2013, Andrew Artz, M.D., M.S., discusses his educational session on Allogeneic Transplant for High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia: Are We Improving Outcomes?

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next